new BindingDB logo
myBDB logout

BDBM285539 3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US9598421, Example 12

SMILES: Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1

InChI Key:

Data: 8 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 285539   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35.8n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 89.6n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.22E+3n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4A (PDE4)


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14.4n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4B (PDE4B)


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 35.8n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
Phosphodiesterase 4C


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 89.6n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US9598421 (2017)


BindingDB Entry DOI: 10.7270/Q2K939KG
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4D


(Homo sapiens (Human))
BDBM285539
PNG
(3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...)
Show SMILES Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.22E+3n/an/an/an/an/an/a



Pfizer Inc.

US Patent




US Patent US10077269 (2018)


BindingDB Entry DOI: 10.7270/Q2P84DX5
More data for this
Ligand-Target Pair